InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

BIOCRYST PHARMACEUTICALS INC

BCRX Clue Score70
United States Fiscal year ends December CIK 0000882796 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

86
Insider
Date
Role
Action
Shares
Price
Amount
Alane P Barnes
13 May 2026
Chief Legal Officer
Sold after exercise
62,500
$9.54
$596.25K
Theresa Heggie
20 Mar 2026
Director
Sold after exercise
49,933
$10.11
$504.82K
Alane P Barnes
16 Mar 2026
Chief Legal Officer
Sold after exercise
150,000
$9.15
$1.37M
Alane P Barnes
1 Dec 2025
Chief Legal Officer
Sold after exercise
91,004
$7.10
$646.51K
Theresa Heggie
13 Aug 2025
Director
Sold after exercise
70,000
$8.51
$595.87K
Jon P Stonehouse
1 Feb 2023
President & CEO
Sold after exercise
100,000
$10.38
$1.04M
Jon P Stonehouse
2 Dec 2022
President & CEO
Sold after exercise
82,656
$12.80
$1.06M
Jon P Stonehouse
1 Dec 2022
President & CEO
Sold after exercise
214,917
$13.00
$2.79M
Michael L Jones
1 Dec 2022
Exec. Director, Finance - PAO
Sold after exercise
8,600
$13.01
$111.89K
Yarlagadda S Babu
14 Nov 2022
Chief Discovery Officer
Sold after exercise
31,515
$13.88
$437.43K
George B Abercrombie
18 Apr 2022
Director
Sold after exercise
5,000
$11.04
$55.20K
William P Sheridan
10 Mar 2022
Chief Medical Officer
Sold after exercise
1,400
$17.64
$24.70K
William P Sheridan
10 Mar 2022
Chief Medical Officer
Sold after exercise
159,739
$16.87
$2.69M
Michael L Jones
1 Mar 2022
Exec. Director, Finance - PAO
Sold after exercise
2,300
$17.20
$39.56K
George B Abercrombie
15 Feb 2022
Director
Sold after exercise
5,000
$18.50
$92.50K
Jon P Stonehouse
11 Jan 2022
President & CEO
Sold after exercise
184,000
$15.04
$2.77M
Yarlagadda S Babu
7 Dec 2021
Chief Discovery Officer
Sold after exercise
30,100
$12.20
$367.22K
George B Abercrombie
15 Nov 2021
Director
Sold after exercise
5,000
$12.27
$61.35K
Nancy J Hutson
15 Oct 2021
Director
Sold after exercise
105,000
$15.40
$1.62M
George B Abercrombie
15 Sep 2021
Director
Sold after exercise
5,000
$15.06
$75.30K
Kenneth B Lee Jr
13 Sep 2021
Director
Sold after exercise
6,000
$15.35
$92.10K
George B Abercrombie
10 Sep 2021
Director
Sold after exercise
74,000
$15.09
$1.12M
George B Abercrombie
15 Jul 2021
Director
Sold after exercise
5,000
$15.69
$78.45K
Nancy J Hutson
10 Jun 2021
Director
Sold after exercise
23,333
$16.86
$393.39K
William P Sheridan
28 May 2021
Chief Medical Officer
Sold after exercise
91,814
$15.02
$1.38M
William P Sheridan
27 May 2021
Chief Medical Officer
Sold after exercise
71,759
$15.00
$1.08M
George B Abercrombie
24 May 2021
Director
Sold after exercise
6,667
$13.90
$92.67K
Alane P Barnes
11 May 2021
Chief Legal Officer
Sold after exercise
102,780
$12.04
$1.24M
William P Sheridan
22 Feb 2021
Senior VP - CMO
Sold after exercise
41,250
$11.57
$477.26K
Jon P Stonehouse
15 Dec 2020
President & CEO
Sold after exercise
134,278
$8.32
$1.12M
Alane P Barnes
11 Dec 2020
Senior VP, Chief Legal Officer
Sold after exercise
13,741
$7.96
$109.38K
Alane P Barnes
4 Dec 2020
Senior VP, Chief Legal Officer
Sold after exercise
13,741
$6.23
$85.61K
Thomas R Staab II
16 May 2019
Senior Vice President and CFO
Sold after exercise
7,250
$7.72
$55.97K
Thomas R Staab II
15 May 2019
Senior Vice President and CFO
Sold after exercise
7,250
$7.92
$57.42K
Thomas R Staab II
14 May 2019
Senior Vice President and CFO
Sold after exercise
4,500
$7.62
$34.29K
Thomas R Staab II
13 May 2019
Senior Vice President and CFO
Sold after exercise
9,750
$7.76
$75.66K
Thomas R Staab II
9 May 2019
Senior Vice President and CFO
Sold after exercise
9,750
$7.63
$74.39K
Thomas R Staab II
6 May 2019
Senior Vice President and CFO
Sold after exercise
9,000
$7.75
$69.75K
Thomas R Staab II
2 May 2019
Senior Vice President and CFO
Sold after exercise
7,750
$7.30
$56.58K
Thomas R Staab II
4 Apr 2019
Senior Vice President and CFO
Sold after exercise
7,500
$8.81
$66.08K
Lynne Powell
28 Jan 2019
Senior VP - CCO
Sold after exercise
2,000
$9.91
$19.82K
Lynne Powell
28 Jan 2019
Senior VP - CCO
Sold after exercise
4,000
$9.88
$39.52K
Thomas R Staab II
28 Jan 2019
Senior Vice President and CFO
Sold after exercise
5,000
$9.85
$49.25K
Lynne Powell
25 Jan 2019
Senior VP - CCO
Sold after exercise
6,000
$9.60
$57.60K
Lynne Powell
18 Jan 2019
Senior VP - CCO
Sold after exercise
2,000
$9.40
$18.80K
Lynne Powell
16 Jan 2019
Senior VP - CCO
Sold after exercise
3,046
$9.27
$28.24K
Lynne Powell
14 Jan 2019
Senior VP - CCO
Sold after exercise
954
$9.20
$8.78K
Lynne Powell
10 Dec 2018
Senior VP - CCO
Sold after exercise
2,000
$9.11
$18.22K
Lynne Powell
10 Dec 2018
Senior VP - CCO
Sold after exercise
2,000
$9.01
$18.02K
Jon P Stonehouse
3 Dec 2018
President & CEO
Sold after exercise
80,000
$9.12
$729.60K
Alane P Barnes
30 Nov 2018
Senior VP, Chief Legal Officer
Sold after exercise
44,290
$9.07
$401.71K
Thomas R Staab II
23 Nov 2018
Senior Vice President and CFO
Sold after exercise
3,500
$9.66
$33.81K
Thomas R Staab II
21 Nov 2018
Senior Vice President and CFO
Sold after exercise
7,000
$9.08
$63.56K
Thomas R Staab II
21 Nov 2018
Senior Vice President and CFO
Sold after exercise
5,000
$9.41
$47.05K
Lynne Powell
21 Nov 2018
Senior VP - CCO
Sold after exercise
2,455
$9.01
$22.12K
Lynne Powell
21 Nov 2018
Senior VP - CCO
Sold after exercise
12,000
$9.06
$108.72K
Thomas R Staab II
20 Nov 2018
Senior Vice President and CFO
Sold after exercise
6,500
$8.75
$56.88K
Thomas R Staab II
20 Nov 2018
Senior Vice President and CFO
Sold after exercise
4,623
$8.57
$39.62K
Lynne Powell
20 Nov 2018
Senior VP - CCO
Sold after exercise
6,150
$8.61
$52.95K
Lynne Powell
20 Nov 2018
Senior VP - CCO
Sold after exercise
9,127
$8.52
$77.76K
Thomas R Staab II
19 Nov 2018
Senior Vice President and CFO
Sold after exercise
75
$8.30
$622.50
Lynne Powell
19 Nov 2018
Senior VP - CCO
Sold after exercise
193
$8.30
$1.60K
Lynne Powell
8 Nov 2018
Senior VP - CCO
Sold after exercise
5,280
$8.15
$43.03K
Thomas R Staab II
8 Nov 2018
Senior Vice President and CFO
Sold after exercise
2,302
$8.30
$19.11K
Thomas R Staab II
8 Nov 2018
Senior Vice President and CFO
Sold after exercise
11,113
$8.09
$89.90K
Lynne Powell
7 Nov 2018
Senior VP - CCO
Sold after exercise
300
$8.00
$2.40K
Thomas R Staab II
7 Nov 2018
Senior Vice President and CFO
Sold after exercise
672
$8.00
$5.38K
Thomas R Staab II
5 Nov 2018
Senior Vice President and CFO
Sold after exercise
215
$8.00
$1.72K
Lynne Powell
5 Nov 2018
Senior VP - CCO
Sold after exercise
100
$8.00
$800.00
Thomas R Staab II
2 Nov 2018
Senior Vice President and CFO
Sold after exercise
3,500
$7.96
$27.86K
Thomas R Staab II
2 Nov 2018
Senior Vice President and CFO
Sold after exercise
7,356
$7.78
$57.23K
Lynne Powell
2 Nov 2018
Senior VP - CCO
Sold after exercise
1,000
$8.00
$8.00K
Thomas R Staab II
19 Oct 2018
Senior Vice President and CFO
Sold after exercise
3,150
$7.45
$23.47K
Thomas R Staab II
3 Oct 2018
Senior Vice President and CFO
Sold after exercise
100
$7.45
$745.00
Thomas R Staab II
3 Oct 2018
Senior Vice President and CFO
Sold after exercise
972
$7.26
$7.06K
Thomas R Staab II
2 Oct 2018
Senior Vice President and CFO
Sold after exercise
5,528
$7.27
$40.19K
Thomas R Staab II
2 Oct 2018
Senior Vice President and CFO
Sold after exercise
3,250
$7.19
$23.37K
William P Sheridan
9 Aug 2018
Senior VP - CMO
Sold after exercise
62,500
$7.03
$439.38K
William P Sheridan
1 Jun 2018
Senior VP - CMO
Sold after exercise
42,112
$6.30
$265.31K
Fred E Cohen
18 Sep 2017
Director
Sold after exercise
54,250
$5.42
$294.04K
Thomas R Staab II
20 Mar 2017
Senior Vice President and CFO
Sold after exercise
3,250
$9.20
$29.90K
Thomas R Staab II
10 Mar 2017
Senior Vice President and CFO
Sold after exercise
3,250
$9.06
$29.45K
Thomas R Staab II
8 Mar 2017
Senior Vice President and CFO
Sold after exercise
3,250
$8.65
$28.11K
Thomas R Staab II
8 Mar 2017
Senior Vice President and CFO
Sold after exercise
3,250
$8.20
$26.65K
Thomas R Staab II
6 Mar 2017
Senior Vice President and CFO
Sold after exercise
3,250
$7.90
$25.68K
Thomas R Staab II
19 Dec 2016
Senior Vice President and CFO
Sold after exercise
3,250
$7.45
$24.21K
Show all 159 transactions →

What was left out

Form 4 filings counted 457
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 86
Sales at will 21
Transactions with no price 0
Shares from compensation/vesting 8,263,448
Sales filed before the plan box existed 15
History held since 3 Nov 2006